Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T helper type 1 (Th1) cell response refers to the immune activities mediated by a specialized subset of CD4+ T helper cells known as Th1 cells. These cells are central to cell-mediated immunity, particularly in defending against intracellular pathogens such as viruses, certain bacteria (e.g., *Mycobacterium tuberculosis*), and protozoa. Th1 responses are characterized by the secretion of specific cytokines that activate macrophages, cytotoxic T lymphocytes, and promote phagocyte-dependent protective mechanisms.
N/A - This is a response, not a direct target.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T Helper Type 1 Cell Response (Th1 Response).